Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Magda Stumpfova
Observed institutions:
Broad Institute,
Brigham and Women's Hospital,
Harvard University,
Dana-Farber Cancer Institute,
Dana-Farber Brigham Cancer Center,
Columbia University
show all 6
OpenAlex ID:
A5082018611
A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
2011
·
Takaaki Sasaki
, Jussi Koivunen
, et al.
·
Cancer Research
·
597
Identification of epidermal progenitors for the Merkel cell lineage
2010
·
Seung-Hyun Woo
, Magda Stumpfova
, et al.
·
Development
·
83
The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2010
·
Magda Stumpfova
, Desirée Ratner
, et al.
·
Cancer Research
·
80
Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
2012
·
Magda Stumpfova
, Pasi A. Jänne
·
Clinical Cancer Research
·
30
Identification of epidermal progenitors for the Merkel cell lineage
2012
·
Seung-Hyun Woo
, Magda Stumpfova
, et al.
·
Development
·
2
Related Article from Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
2023
·
Magda Stumpfova
, Pasi A. Jänne
Related Article from Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
2023
·
Magda Stumpfova
, Pasi A. Jänne
Data from Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
2023
·
Magda Stumpfova
, Pasi A. Jänne
Data from Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
2023
·
Magda Stumpfova
, Pasi A. Jänne
Supplementary Figures 1-4 from A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
2023
·
Takaaki Sasaki
, Jussi Koivunen
, et al.
Supplementary Materials and Methods from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
PDF
Supplementary Figure 4 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
Supplementary Figure 3 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
PDF
Supplementary Figure Legends 1-4 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
PDF
Supplementary Figure 1 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
PDF
Supplementary Figure 2 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
PDF
Supplementary Table 1 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
PDF
Supplementary Figure 3 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
Supplementary Table 1 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
Supplementary Materials and Methods from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
Supplementary Figures 1-4 from A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
2023
·
Takaaki Sasaki
, Jussi Koivunen
, et al.
PDF
Supplementary Figure 2 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
Supplementary Figure 1 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
Supplementary Figure Legends 1-4 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
Supplementary Figure 4 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
2023
·
Magda Stumpfova
, Desirée Ratner
, et al.
PDF
Show more works
View as search
Works count:
30
Citation count:
792
H-index:
4
I10-index:
4
Year
Topic
Type